Public Health Partnerships Sanofi Pasteur’s global vaccine leadership and recent pediatric partnership activity position the company to expand joint vaccination programs with hospitals, clinics, and public health authorities. Sales opportunities include co-funded immunization campaigns, vaccine distribution collaborations, and regional public-health contracts that leverage their scale and product portfolio.

T1D Collaboration Expansion The ongoing Type 1 Diabetes screening collaborations demonstrate a receptiveness to data-driven care networks. There is potential to replicate and scale across states by offering integrated screening, referral platforms, and patient-management tools to pediatric practices, endocrinology clinics, and health plans.

AI-Driven Discovery Investments in agentic AI for drug discovery indicate interest in advanced data science partnerships. Propose AI-enabled trial design, real-world evidence programs, and data platform services that accelerate research timelines, regulatory submissions, and post-market insights.

Digital Engagement Digital tools and identity-focused security capabilities suggest an opportunity to modernize vaccine information delivery, appointment scheduling, and provider support. Offer tailored digital engagement solutions, CRM enhancements, and field-force enablement that improve outreach and adherence.

Risk & Compliance Exposure to regulatory and litigation risk creates demand for risk intelligence, pharmacovigilance, and regulatory compliance services. Position offerings around adverse event analytics, safety monitoring, and lifecycle-contract management to protect brand value and streamline compliance.